Industry News | 2008-03-26 12:49:54.0
WALTHAM, Mass.--(BUSINESS WIRE)--March 26, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today celebrated the opening of a new Center of Excellence in Singapore. The PerkinElmer Inc. Center of Excellence in Singapore comes as part of PerkinElmer's continued global R&D expansion efforts, and will focus on the development of new precision instrumentation and chemistries for a range of scientific and industrial laboratory applications, including drug discovery and development, environmental monitoring, food safety, and sustainable energy.
Industry News | 2009-02-06 02:42:58.0
WALTHAM, Mass., Feb 03, 2009 (BUSINESS WIRE) PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, announced the acquisition of Opto Technology, Inc., a leading supplier of light-emitting diode (LED) based lighting components and subsystems.
Industry News | 2008-03-01 15:14:33.0
WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 29, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced that it has successfully completed its acquisition of the newborn metabolic screening business of Pediatrix Medical Group, Inc. (NYSE: PDX). The completion of this transaction expands PerkinElmer's capabilities in the neonatal health field.
Industry News | 2007-10-11 23:25:15.0
WALTHAM, Mass.-Oct. 11, 2007-PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, today announced a complete analytical solution for the determination of melamine adulteration in protein-based foods. With the release of the Melamine Analyzer, based on the innovative Clarus(R) 600 T Gas Chromatograph/Mass Spectrometer (GC/MS), PerkinElmer is the first in the industry to provide such solution using GC/MS technology.
Industry News | 2008-05-23 18:24:21.0
WALTHAM, Mass.--(BUSINESS WIRE)--May 19, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced that Michael L. Battles, the Company's vice president and controller, will lead the finance function on an interim basis, reporting directly to president and chief executive officer, Robert F. Friel. PerkinElmer's current chief financial officer, Jeffrey D. Capello, is resigning to pursue another opportunity outside the Company effective June 6, 2008.
Industry News | 2007-12-27 01:28:09.0
WALTHAM, Mass.--(BUSINESS WIRE)--Dec. 19, 2007--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced the signing of a definitive agreement with Pediatrix Medical Group, Inc. (NYSE: PDX) under which PerkinElmer will acquire the newborn metabolic screening business of Pediatrix in a cash transaction.
Industry News | 2007-11-15 19:49:44.0
WALTHAM, Mass.--(BUSINESS WIRE)--Nov. 15, 2007--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced that it has successfully completed its acquisition of ViaCell, Inc., a biotechnology company specializing in the collection and preservation of umbilical cord blood stem cells.
Industry News | 2008-03-03 22:11:57.0
NEW ORLEANS-March 3, 2008--PerkinElmer, Inc.(NYSE: PKI), a global leader in health sciences and photonics, today announced that it is showcasing its new EcoAnalytix(TM) initiative at PITTCON(R) 2008, March 2-6, 2008 Booth #2555. EcoAnalytix is PerkinElmer's revolutionary problem-solving initiative that addresses the global imperatives of food and consumer product safety, water quality and sustainable energy development.
Industry News | 2008-07-14 14:00:39.0
WALTHAM, Mass.--(BUSINESS WIRE)--July 14, 2008--PerkinElmer, Inc. (NYSE: PKI), a leader in Health Sciences and Photonics, today announced that Alan Fletcher, Ph.D., has joined the Company as vice president, business development for PerkinElmer's Life and Analytical Sciences business. In this role, Fletcher will be responsible for growing the Bio-discovery business through the development of strategic partnerships and alliances in the life science research area, and the introduction of new technologies for GPCR, kinase and biomarker drug target classes.
Industry News | 2007-10-01 13:13:48.0
SANTA CLARA, Calif.-Sept. 28, 2007-PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced the expansion of its Santa Clara, California, digital x-ray detector fabrication facility. The 80,000-square foot facility produces amorphous silicon digital x-ray detector panels for use in radiography, angiography, cardiovascular imaging, and radiation oncology.
